Impact BioMedical, INC. Investment Income, Interest
Impact BioMedical, INC. (IBO) reported Investment Income, Interest of $2.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2026-08-07
- Impact BioMedical, INC. investment income, interest for the quarter ending 2026-06-30 was $2.00K, a 33.33% decline year-over-year.
- Impact BioMedical, INC. investment income, interest for the quarter ending 2026-03-31 was $5.00K, a 66.67% increase year-over-year.
- Impact BioMedical, INC. investment income, interest for the quarter ending 2025-06-30 was $3.00K, a 0.00% change year-over-year.
- Impact BioMedical, INC. investment income, interest for the quarter ending 2025-03-31 was $3.00K, a 0.00% change year-over-year.
- Impact BioMedical, INC. investment income, interest for fiscal 2023 was $13.00K, a 45.83% decline from fiscal 2022.
- Impact BioMedical, INC. investment income, interest for fiscal 2022 was $24.00K.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.00K 10-Q · filed 2026-08-07 | $7.00K 10-Q · filed 2026-08-07 | ||
| 2026-03-31 | $5.00K 10-Q · filed 2026-05-12 | |||
| 2025-06-30 | $3.00K 10-Q · filed 2026-08-07 | $7.00K 10-Q · filed 2026-08-07 | ||
| 2025-03-31 | $3.00K 10-Q · filed 2026-05-12 | |||
| 2024-06-30 | $3.00K 10-Q · filed 2024-08-13 | $7.00K 10-Q · filed 2024-08-13 | $9.00K derived: sum of 3 quarters · filed 2024-08-13 | $12.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | $3.00K 10-Q · filed 2024-05-10 | $6.00K derived: sum of 2 quarters · filed 2024-05-10 | $9.00K derived: sum of 3 quarters · filed 2024-05-10 | $12.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | $6.00K derived: sum of 2 quarters · filed 2024-02-20 | $9.00K derived: sum of 3 quarters · filed 2024-08-13 | $13.00K 10-K · filed 2024-02-20 |
| 2023-09-30 | $3.00K 10-Q · filed 2023-11-13 | $6.00K derived: sum of 2 quarters · filed 2024-08-13 | $10.00K 10-Q · filed 2023-11-13 | -$71.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-06-30 | $3.00K 10-Q · filed 2024-08-13 | $7.00K 10-Q · filed 2024-08-13 | -$74.00K derived: sum of 3 quarters · filed 2024-08-13 | -$71.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $3.00K 10-Q · filed 2024-05-10 | -$77.00K derived: sum of 2 quarters · filed 2024-05-10 | -$74.00K derived: sum of 3 quarters · filed 2024-05-10 | $16.00K derived: sum of 4 quarters · filed 2024-05-10 |
| 2022-12-31 | -$80.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-20 | -$77.00K derived: sum of 2 quarters · filed 2024-02-20 | $13.00K derived: sum of 3 quarters · filed 2024-02-20 | $24.00K 10-K · filed 2024-02-20 |
| 2022-09-30 | $3.00K 10-Q · filed 2023-11-13 | $93.00K derived: sum of 2 quarters · filed 2023-11-13 | $104.00K 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $90.00K 10-Q · filed 2023-10-05 | $186.00K 10-Q · filed 2023-10-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| CytomX Therapeutics, Inc. (CTMX) | United States | $0.598B | -10.25 |
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| ZEVRA THERAPEUTICS, INC. (ZVRA) | United States | $0.668B | 14.61 |